Strategic Wealth Partners Ltd. Reduces Position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM)

Strategic Wealth Partners Ltd. lessened its holdings in shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDMGet Rating) by 5.5% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 11,508 shares of the medical device company’s stock after selling 674 shares during the period. Strategic Wealth Partners Ltd.’s holdings in Tandem Diabetes Care were worth $1,338,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the business. Treasurer of the State of North Carolina raised its stake in shares of Tandem Diabetes Care by 1.6% during the first quarter. Treasurer of the State of North Carolina now owns 22,802 shares of the medical device company’s stock valued at $2,652,000 after acquiring an additional 363 shares in the last quarter. Teacher Retirement System of Texas raised its stake in shares of Tandem Diabetes Care by 8.3% during the first quarter. Teacher Retirement System of Texas now owns 13,141 shares of the medical device company’s stock valued at $1,528,000 after acquiring an additional 1,008 shares in the last quarter. GSA Capital Partners LLP bought a new position in Tandem Diabetes Care in the first quarter worth approximately $467,000. Nuveen Asset Management LLC raised its stake in Tandem Diabetes Care by 1.8% in the fourth quarter. Nuveen Asset Management LLC now owns 331,469 shares of the medical device company’s stock worth $49,893,000 after buying an additional 5,838 shares in the last quarter. Finally, Louisiana State Employees Retirement System raised its stake in Tandem Diabetes Care by 1.8% in the first quarter. Louisiana State Employees Retirement System now owns 16,600 shares of the medical device company’s stock worth $1,935,000 after buying an additional 300 shares in the last quarter. Hedge funds and other institutional investors own 95.28% of the company’s stock.

Analyst Upgrades and Downgrades

TNDM has been the subject of a number of recent research reports. Robert W. Baird reduced their price objective on shares of Tandem Diabetes Care to $76.00 in a research note on Tuesday, August 9th. Lake Street Capital reduced their price objective on shares of Tandem Diabetes Care from $200.00 to $150.00 in a research note on Thursday, August 4th. Raymond James reduced their price objective on shares of Tandem Diabetes Care from $125.00 to $90.00 and set an “outperform” rating for the company in a research note on Thursday, August 4th. Cowen reduced their price objective on shares of Tandem Diabetes Care from $141.00 to $107.00 in a research note on Thursday, August 4th. Finally, Cowen cut their price target on shares of Tandem Diabetes Care from $141.00 to $107.00 in a report on Thursday, August 4th. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, Tandem Diabetes Care currently has a consensus rating of “Hold” and a consensus price target of $103.36.

Tandem Diabetes Care Price Performance

Shares of TNDM opened at $58.03 on Thursday. The firm has a market capitalization of $3.73 billion, a PE ratio of -263.77 and a beta of 0.95. The company has a debt-to-equity ratio of 0.63, a current ratio of 6.00 and a quick ratio of 5.36. Tandem Diabetes Care, Inc. has a 1-year low of $42.90 and a 1-year high of $155.86. The company’s fifty day moving average price is $55.16 and its 200-day moving average price is $77.17.

Tandem Diabetes Care Company Profile

(Get Rating)

Tandem Diabetes Care, Inc, a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set.

Read More

Institutional Ownership by Quarter for Tandem Diabetes Care (NASDAQ:TNDM)

Receive News & Ratings for Tandem Diabetes Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tandem Diabetes Care and related companies with MarketBeat.com's FREE daily email newsletter.